Senate Health, Education, Labor & Pensions Committee Issues Testimony From Novo Nordisk President Jorgensen
May 24, 2023
May 24, 2023
WASHINGTON, May 24 -- The Senate Health, Education, Labor and Pensions Committee issued the following testimony by Lars Fruergaard Jorgensen, president and CEO of Novo Nordisk, involving a hearing on May 10, 2023, entitled "The Need to Make Insulin Affordable for All Americans":
* * *
Thank you for holding this hearing and for giving me an opportunity to speak today on behalf of Novo Nordisk.
At Novo Nordisk, our mission is to pioneer scientific b . . .
* * *
Thank you for holding this hearing and for giving me an opportunity to speak today on behalf of Novo Nordisk.
At Novo Nordisk, our mission is to pioneer scientific b . . .